103 related articles for article (PubMed ID: 3109313)
1. Enhanced chemotherapeutic efficacy on carcinomatous peritonitis using a new dosage form in animal experiments.
Hagiwara A; Takahashi T; Lee R; Ueda T; Takeda M; Itoh T
Anticancer Res; 1987; 7(2):167-70. PubMed ID: 3109313
[TBL] [Abstract][Full Text] [Related]
2. Toxicity and pathological effects of a new dosage form of mitomycin C for carcinomatous peritonitis.
Hagiwara A; Takahashi T; Ueda T; Lee R; Takeda M; Itoh T
Anticancer Res; 1987; 7(1):105-8. PubMed ID: 3105418
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anticancer efficacy by use of mitomycin C adsorbed on small activated carbon particles in mice.
Hagiwara A; Takahashi T; Ueda T; Nakagawa Y
Jpn J Cancer Res; 1987 Apr; 78(4):405-8. PubMed ID: 3108220
[TBL] [Abstract][Full Text] [Related]
4. [Targeting chemotherapy with activated carbon particles adsorbing anti-cancer drugs].
Hagiwara A; Takahashi T; Kondoh S; Iwamoto A; Sawai K
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1038-42. PubMed ID: 2455477
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative chemotherapy with carbon particles adsorbing mitomycin C for gastric cancer with peritoneal dissemination in rabbits.
Hagiwara A; Takahashi T; Ueda T; Lee R; Takeda M; Itoh T
Surgery; 1988 Nov; 104(5):874-81. PubMed ID: 3142071
[TBL] [Abstract][Full Text] [Related]
6. Affinity of intraperitoneally injected activated carbon particles adsorbing mitomycin C to tumor surface of Yoshida sarcoma.
Hagiwara A; Takahashi T; Iwamoto A; Yoneyama C; Itoh M; Sasabe T
Anticancer Drug Des; 1990 Nov; 5(4):359-69. PubMed ID: 2127181
[TBL] [Abstract][Full Text] [Related]
7. [Intraoperative chemotherapy with intraperitoneal activated carbon particles adsorbing mitomycin C against peritoneal dissemination of gastric cancer].
Iwamoto A; Takahashi T; Sasabe T; Itoh M; Kondoh S; Seiki K; Yoneyama C; Shimotsuma M; Hagiwara A; Yamaguchi T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2748-51. PubMed ID: 2506820
[TBL] [Abstract][Full Text] [Related]
8. [Intraabdominal administration of MMC adsorbed on activated carbon for management of carcinomatous peritonitis].
Takahashi T; Hagiwara A; Ito T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1550-6. PubMed ID: 6433797
[TBL] [Abstract][Full Text] [Related]
9. Selective delivery of high levels of mitomycin C to peritoneal carcinomatosis using a new dosage form.
Hagiwara A; Takahashi T; Lee R; Ueda T; Takeda M; Itoh T
Anticancer Res; 1986; 6(5):1161-4. PubMed ID: 3099630
[TBL] [Abstract][Full Text] [Related]
10. Animal experiments as a model for clinical trials of a new dosage form of mitomycin C for peritoneal carcinomatosis.
Hagiwara A; Takahashi T; Lee R; Ueda T; Takeda M; Itoh T
In Vivo; 1987; 1(1):43-6. PubMed ID: 2979763
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for carcinomatous peritonitis and pleuritis with MMC-CH, mitomycin C adsorbed on activated carbon particles. Clinical trials.
Hagiwara A; Takahashi T; Lee R; Ueda T; Takeda M; Itoh T
Cancer; 1987 Jan; 59(2):245-51. PubMed ID: 3100014
[TBL] [Abstract][Full Text] [Related]
12. [Intraoperative chemotherapy against peritoneal dissemination of gastric cancer with intraperitoneal activated carbon particles adsorbing mitomycin C].
Hagiwara A; Takahashi T; Sawai K; Yamaguchi T; Iwamoto A; Yoneyama C
Gan To Kagaku Ryoho; 1989 Feb; 16(2):187-92. PubMed ID: 2493221
[TBL] [Abstract][Full Text] [Related]
13. [Intraperitoneal chemotherapy against peritoneal carcinomatosis of gastric cancer with activated carbon particles adsorbing mitomycin C for four patients].
Ohgaki M; Takenaka A; Shiomi A; Chou H; Takashina K; Kawakami S; Fujita Y; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1858-60. PubMed ID: 15553739
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy of carcinomatous peritonitis and carcinomatous pleuritis by using activated charcoal particle adsorbing mitomycin C (MMC-CH)--studies on the clinical trials].
Hagiwara A; Takahashi T; Lee R; Ueda T; Takeda M; Itoh T
Nihon Gan Chiryo Gakkai Shi; 1985 Oct; 20(9):2144-53. PubMed ID: 3937878
[No Abstract] [Full Text] [Related]
15. [Effect on immunological response of host by mitomycin C adsorbed into activated carbon particles (MMC-CH) in mice].
Iwamoto A; Sakita M; Hata K; Hagiwara A; Takahashi T
Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1829-33. PubMed ID: 2514342
[TBL] [Abstract][Full Text] [Related]
16. [The prevention of peritoneal dissemination of gastric cancer with intraperitoneal activated carbon particles absorbing mitomycin C].
Ohgaki M; Imanishi T; Ohyama T; Tsujimoto H; Ozaki K; Chohei S; Shimotsuma M; Hagiwara A; Takahashi T
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2320-2. PubMed ID: 7944469
[TBL] [Abstract][Full Text] [Related]
17. Anticancer agents adsorbed by activated carbon particles, a new form of dosage enhancing efficacy on lymphnodal metastases.
Hagiwara A; Ahn T; Ueda T; Iwamoto A; Ueda T; Torii T; Takahashi T
Anticancer Res; 1986; 6(5):1005-8. PubMed ID: 2432828
[TBL] [Abstract][Full Text] [Related]
18. [Four long-surviving cases of gastric cancer with peritoneal dissemination treated by intraperitoneal administration of mitomycin C adsorbed on activated carbon particles].
Sakakibara T; Oyama T; Ozaki K; Sasaki S; Tsujimoto H; Sakakura C; Shimotsuma M; Hagiwara A; Takahashi T
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1700-2. PubMed ID: 8373253
[TBL] [Abstract][Full Text] [Related]
19. Activated carbon particles as anti-cancer drug carrier into regional lymph nodes.
Hagiwara A; Takahashi T; Ueda T; Iwamoto A; Torii T
Anticancer Drug Des; 1987 Apr; 1(4):313-21. PubMed ID: 2453199
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral treatment of pancreatic cancer with mitomycin-C adsorbed to activated carbon particles. A clinical trial on 15 cases.
Moriai T; Makino TT; Ishii K
Anticancer Res; 1989; 9(6):1799-804. PubMed ID: 2516716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
